Get started
STRIDES PHARMA SCI LTDSTRIDES PHARMA SCI LTDSTRIDES PHARMA SCI LTD

STRIDES PHARMA SCI LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

STAR chart


Full chart

STAR upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪128.05 B‬ INR
Dividend yield (indicated)
0.18%
Price to earnings Ratio (TTM)
71.05
Basic EPS (TTM)
19.25 INR
Net income (FY)
‪−1.25 B‬ INR
Revenue (FY)
‪40.20 B‬ INR
Shares float
‪60.59 M‬
Beta (1Y)
0.70

Employees


Employees (FY)
‪5.21 K‬
Change (1Y)
+589 +12.75%
Revenue / Employee (1Y)
‪92.55 K‬ INR
Net income / Employee (1Y)
‪−2.87 K‬ INR

About STRIDES PHARMA SCI LTD


Sector
Health Technology
CEO
Badree Komandur
Headquarters
Bangalore
Website
strides.com
Founded
1990
ISIN
INE939A01011
FIGI
BBG000DQV3B4
Strides Pharma Science Ltd. engages in the development, manufacture and distribution of Internet Protocol-led generics and bio-pharmaceutical products. It operates through the Pharmaceutical and Bio-pharmaceutical business segments. The company was founded by Arun N. Kumar on June 28, 1990 and is headquartered in Bangalore, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

STAR news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of STAR is 1,503.65 INR — it has increased by 1.90% in the past 24 hours. Watch STRIDES PHARMA SCI LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange STRIDES PHARMA SCI LTD stocks are traded under the ticker STAR.
STAR stock has fallen by −7.80% compared to the previous week, the month change is a −15.15% fall, over the last year STRIDES PHARMA SCI LTD has showed a 202.03% increase.
We've gathered analysts' opinions on STRIDES PHARMA SCI LTD future price: according to them, STAR price has a max estimate of 1,954.00 INR and a min estimate of 1,175.00 INR. Watch STAR chart and read a more detailed STRIDES PHARMA SCI LTD stock forecast: see what analysts think of STRIDES PHARMA SCI LTD and suggest that you do with its stocks.
STAR reached its all-time high on Oct 17, 2024 with the price of 1,675.00 INR, and its all-time low was 46.80 INR and was reached on Jul 19, 2001. View more price dynamics on STAR chart.
See other stocks reaching their highest and lowest prices.
STAR stock is 9.83% volatile and has beta coefficient of 0.70. Track STRIDES PHARMA SCI LTD stock price on the chart and check out the list of the most volatile stocks — is STRIDES PHARMA SCI LTD there?
Today STRIDES PHARMA SCI LTD has the market capitalization of ‪128.05 B‬, it has increased by 0.24% over the last week.
Yes, you can track STRIDES PHARMA SCI LTD financials in yearly and quarterly reports right on TradingView.
STRIDES PHARMA SCI LTD is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
STAR net income for the last quarter is ‪932.32 M‬ INR, while the quarter before that showed ‪702.02 M‬ INR of net income which accounts for 32.81% change. Track more STRIDES PHARMA SCI LTD financial stats to get the full picture.
Yes, STAR dividends are paid annually. The last dividend per share was 2.50 INR. As of today, Dividend Yield (TTM)% is 0.18%. Tracking STRIDES PHARMA SCI LTD dividends might help you take more informed decisions.
As of Nov 21, 2024, the company has ‪5.21 K‬ employees. See our rating of the largest employees — is STRIDES PHARMA SCI LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STRIDES PHARMA SCI LTD EBITDA is ‪8.76 B‬ INR, and current EBITDA margin is 17.58%. See more stats in STRIDES PHARMA SCI LTD financial statements.
Like other stocks, STAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STRIDES PHARMA SCI LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So STRIDES PHARMA SCI LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating STRIDES PHARMA SCI LTD stock shows the buy signal. See more of STRIDES PHARMA SCI LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.